| [1] |
Sabbah DA, Hajjo R, Sweidan K. Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors[J]. Curr Top Med Chem, 2020, 20(10): 815-834.
|
| [2] |
Yacoub A, McKinstry R, Hinman D, et al. Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling[J]. Radiat Res, 2003, 159(4): 439-452.
|
| [3] |
Rajaram P, Chandra P, Ticku S, et al. Epidermal growth factor receptor: role in human cancer[J]. Indian J Dent Res, 2017, 28(6): 687-694.
|
| [4] |
Sigismund S, Avanzato D, Lanzetti L. Emerging functions of the EGFR in cancer[J]. Mol Oncol, 2018, 12(1): 3-20.
|
| [5] |
Cheng WL, Feng PH, Lee KY, et al. The Role of EREG/EGFR pathway in tumor progression[J].Int J Mol Sci, 2021, 22(23): 12828.
|
| [6] |
Wilson MA, Schuchter LM. Chemotherapy for melanoma[J]. Cancer Treat Res, 2016, 167: 209-229.
|
| [7] |
Baer JC, Freeman AA, Newlands ES, et al. Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells[J]. Br J Cancer, 1993, 67(6): 1299-1302.
|
| [8] |
Rabik CA, Njoku MC, Dolan ME. Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy[J]. Cancer Treat Rev, 2006, 32(4): 261-276.
|
| [9] |
Zanchi C, Zuco V, Lanzi C, et al. Modulation of survival signaling pathways and persistence of the genotoxic stress as a basis for the synergistic interaction between the atypical retinoid ST1926 and the epidermal growth factor receptor inhibitor ZD1839[J]. Cancer Res, 2005, 65(6): 2364-2372.
|
| [10] |
Zuco V, Benedetti V, De Cesare M, et al. Sensitization of ovarian carcinoma cells to the atypical retinoid ST1926 by the histone deacetylase inhibitor, RC307: enhanced DNA damage response[J]. Int J Cancer, 2010, 126(5): 1246-1255.
|
| [11] |
Knight ZA, Lin H, Shokat KM. Targeting the cancer kinome through polypharmacology[J]. Nat Rev Cancer, 2010, 10(2): 130-137.
|
| [12] |
Qiu Q, Domarkas J, Banerjee R, et al. The combi-targeting concept: in vitro and in vivo fragmentation of a stable combi-nitrosourea engineered to interact with the epidermal growth factor receptor while remaining DNA reactive[J]. Clin Cancer Res, 2007, 13(1): 331-340.
|
| [13] |
Rachid Z, Brahimi F, Katsoulas A, et al. The combi-targeting concept: chemical dissection of the dual targeting properties of a series of "combi-triazenes"[J]. J Med Chem, 2003, 46(20): 4313-4321.
|
| [14] |
Fang YQ, Wu JY, Li TC, et al. Nanoparticle mediated chemotherapy of hormone refractory prostate cancer with a novel combi-molecule[J]. Am J Transl Res. 2015, 7(8): 1440-1449.
|
| [15] |
Fang YQ, Wu JY, Li TC, et al. Biological effects of novel "combi-targeting" molecule and its effect on DNA repair pathway in hormone-refractory prostate cancer[J]. Am J Cancer Res. 2015, 5(8): 2387-2395.
|
| [16] |
Larroque AL, Peori B, Williams C, et al. Synthesis of water soluble bis-triazenoquinazolines: an unusual predicted mode of binding to the epidermal growth factor receptor tyrosine kinase[J]. Chem Biol Drug Des, 2008, 71(4): 374-379.
|
| [17] |
Matheson SL, McNamee JP, Wang T, et al. The combi-targeting concept: dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo[J]. J Pharmacol Exp Ther, 2004, 311(3): 1163-1170.
|
| [18] |
Matheson SL, Brahimi F, Jean-Claude BJ. The combi-targetinG concept: intracellular fragmentation of the binary epidermal growth factor (EGFR)/DNA targeting "combi-triazene" SMA41[J]. Biochem Pharmacol, 2004, 67(6): 1131-1138.
|
| [19] |
Banerjee R, Huang Y, McNamee J P, et al. The combi-targeting concept: selective targeting of the epidermal growth factor receptor- and Her2-expressing cancer cells by the complex combi-molecule RB24[J]. J Pharmacol Exp Ther, 2010, 334(1): 9-20.
|
| [20] |
Banerjee R, Huang Y, Qiu Q, et al. The combi-targeting concept: mechanism of action of the pleiotropic combi-molecule RB24 and discovery of a novel cell signaling-based combination principle[J]. Cell Signal, 2011, 23(4): 630-640.
|